Heterotaxia autosomal dominant type
Heterotaxia autosomal dominant type is a rare genetic condition characterized by the abnormal arrangement of internal organs along the left-right axis of the body. This condition is part of a broader group of disorders known as heterotaxy syndrome or situs ambiguus. Heterotaxia can affect various organs, including the heart, liver, spleen, and intestines, leading to a wide range of clinical manifestations and health issues. The autosomal dominant type indicates that the condition can be inherited from just one affected parent due to mutations in specific genes that follow an autosomal dominant pattern of inheritance.
Causes and Genetics[edit | edit source]
The genetic basis of heterotaxia autosomal dominant type involves mutations in genes that are crucial for the proper left-right organization of the internal organs during embryonic development. While several genes have been associated with heterotaxy, mutations in the ZIC3 gene are most commonly linked to the autosomal dominant form of the condition. The ZIC3 gene plays a significant role in early embryonic development, including the development of the heart and other organs. Mutations in this gene disrupt the normal left-right patterning, leading to the heterotaxic arrangement of organs.
Symptoms and Diagnosis[edit | edit source]
Symptoms of heterotaxia autosomal dominant type vary widely among individuals, depending on the organs affected and the extent of their malposition. Common manifestations include congenital heart defects, such as atrial septal defect (ASD) and ventricular septal defect (VSD), abnormalities in the arrangement and number of spleen (asplenia or polysplenia), and malformations of the liver and intestines. Respiratory issues and immune deficiencies may also occur due to the abnormal positioning or absence of the spleen.
Diagnosis of heterotaxia involves a combination of physical examination, imaging studies such as echocardiography, MRI, and CT scans, and genetic testing to identify mutations in the ZIC3 gene or other genes associated with the condition.
Treatment and Management[edit | edit source]
Treatment of heterotaxia autosomal dominant type is tailored to the specific symptoms and organ involvements of each individual. Management may include surgical correction of congenital heart defects, preventive measures for infections due to spleen abnormalities, and monitoring and treatment of other organ-related issues. Multidisciplinary care from cardiologists, surgeons, immunologists, and other specialists is often required to address the complex needs of individuals with heterotaxia.
Prognosis[edit | edit source]
The prognosis for individuals with heterotaxia autosomal dominant type varies widely and depends on the severity of the organ malformations and the presence of congenital heart defects. Early diagnosis and appropriate management of the condition and its complications can improve the quality of life and outcomes for affected individuals.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD